HR 5745 United States House · 117th Congress

COVID–19 Access to Testing and Support for Immune Response Research Act of 2021

Summary
COVID-19 Access to Testing and Support for Immune Response Research Act of 2021 This bill requires the Centers for Medicare & Medicaid Services to provide for coverage during the COVID-19 public health emergency of T-cell diagnostic laboratory tests for individuals with a current or prior COVID-19 infection. In addition, the Department of Health and Human Services must develop a national strategy to research the immune response to COVID-19 and may award research grants.
Bill status in committee 1 of 4 stages cleared
Introduction
Oct 2021
Committee Review
Floor Vote
President
Introduced Oct 27, 2021 Last action Oct 28, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
0
Committee
3
Oct 28, 2021
Committee
Referred to the Subcommittee on Health.
lower
Oct 27, 2021
Committee
Referred to the Subcommittee on Health.
lower
Oct 27, 2021
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Oct 27, 2021
Introduced
Introduced in House
lower
1 primary · 2 co-sponsors

Sponsors